Spire Wealth Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.2K Sell
61
-35
-36% -$6.7K ﹤0.01% 1563
2026
Q1
$17.6K Sell
96
-63
-40% -$11.6K ﹤0.01% 1465
2025
Q4
$28K Sell
159
-7
-4% -$1.14K ﹤0.01% 1357
2025
Q3
$23.3K Buy
166
+18
+12% +$2.43K ﹤0.01% 1483
2025
Q2
$18.6K Sell
148
-23
-13% -$2.87K ﹤0.01% 1536
2025
Q1
$23.5K Buy
171
+45
+36% +$6.43K ﹤0.01% 1555
2024
Q4
$19.2K Sell
126
-129
-51% -$21.8K ﹤0.01% 1636
2024
Q3
$49.4K Buy
255
+28
+12% +$5.86K ﹤0.01% 1135
2024
Q2
$52.6K Sell
227
-283
-55% -$61.5K ﹤0.01% 1102
2024
Q1
$110K Sell
510
-126
-20% -$29.5K ﹤0.01% 967
2023
Q4
$159K Buy
636
+55
+9% +$13.5K 0.01% 829
2023
Q3
$149K Sell
581
-99
-15% -$26.5K 0.01% 808
2023
Q2
$194K Sell
680
-14
-2% -$4.17K 0.01% 724
2023
Q1
$193K Buy
694
+316
+84% +$87.4K 0.01% 733
2022
Q4
$105K Buy
378
+43
+13% +$12.1K 0.01% 724
2022
Q3
$89K Sell
335
-193
-37% -$41K 0.01% 747
2022
Q2
$108K Sell
528
-497
-48% -$102K ﹤0.01% 1006
2022
Q1
$216K Sell
1,025
-1,334
-57% -$290K 0.01% 858
2021
Q4
$566K Buy
2,359
+1,244
+112% +$320K 0.01% 653
2021
Q3
$316K Hold
1,115
0.01% 732
2021
Q2
$386K Sell
1,115
-1,425
-56% -$432K 0.01% 694
2021
Q1
$707K Buy
+2,540
New +$685K 0.02% 556

Other funds holding BIIB

Spire Wealth Management's BIIB Position: Q2 2026 in Review

Spire Wealth Management reduced its Biogen (BIIB) stake by 36% in Q2 2026, selling an estimated $6.7K and leaving 61 shares worth $13.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1563.

Spire Wealth Management first reported a position in BIIB in Q1 2021 and has held it in 22 quarters since. The position peaked at $707K in Q1 2021. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Spire Wealth Management held 61 shares of Biogen worth $13.2K as of Q2 2026.
  • Spire Wealth Management sold 35 Biogen shares in Q2 2026, an estimated $6.7K.
  • Biogen made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #1563 holding.
  • Spire Wealth Management first reported a position in Biogen in Q1 2021 and has held it in 22 quarters since.
  • Spire Wealth Management's Biogen position peaked at $707K in Q1 2021.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.